AMED Nasdaq· Amedisys Inc
FundamentalsNews digest Peer analysis
AMED Nasdaq· Amedisys Inc
Earnings report Q3 2023

AMED's Revenue Slightly Decreases Amidst Operational Improvements

Segments of revenue

AMED's net service revenue for the three-month period ending September 30, 2023, was $556.2 million, a slight decrease from the $558 million reported in the same period in 2022.


Despite the slight decrease in net service revenue, the company's operating income increased by $3 million. This improvement can be attributed to a decrease in the cost of service, inclusive of depreciation, which fell from $322.2 million to $311.6 million. The company also managed to reduce its depreciation and amortization expenses from $5.5 million to $4.4 million.


The company faced challenges in the form of increased general and administrative expenses, which rose from $188.4 million to $198 million. Furthermore, the company's effective income tax rate increased from 27% to 32.5%, leading to a higher income tax expense of $12.3 million, up from $9.4 million in the previous year.


The company's year-over-year results were impacted by merger-related expenses totaling $5 million and higher incentive compensation costs totaling $11 million. The divestiture of the personal care line of business, which contributed $17 million in revenue and operating income of $2 million in the prior year, also affected the results.


In summary, AMED's latest quarter saw a slight decrease in net service revenue, but the company managed to increase its operating income. The company faced increased general and administrative expenses and a higher effective income tax rate. The divestiture of the personal care line of business and merger-related expenses also impacted the results. Despite these challenges, the company's ability to reduce costs and depreciation expenses demonstrates operational improvements.

Source documents

Form 10-Q  filed on Oct 25, 2023
98 pages scanned

Reference data

Company financials Q3 revenue 571M
Analyst estimates Q3 EPS missed by -9.09%
Sign up to Fey

Get in-depth analysis on thousands of stocks for just $30/month. Cancel anytime.